BiotechTube
Home/Enabled Therapeutics/Jivan Achreja
JA

Jivan Achreja

Board Member

Enabled Therapeutics

Therapeutic Areas

NeurodegenerationCentral Nervous System

Enabled Therapeutics Pipeline

DrugIndicationPhase
CPT-021Alzheimer's DiseasePre-clinical